![Raymond de Vre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raymond de Vre
Directeur/Membre du Conseil chez
CODEXIS, INC.
Fortune : 144 179 $ au 31/08/2026
Profil
Dr. Raymond de Vre is an Independent Director at EQL Pharma AB, an Independent Director at Codexis, Inc. and a Chairman at PolyPeptide Laboratories A/S.
He is on the Board of Directors at EQL Pharma AB, Codexis, Inc. and Aurigene Oncology Ltd. Dr. de Vre was previously employed as a Chief Executive Officer by PolyPeptide Group AG, a Senior Vice President-Global Business Operations by Reddys Medicare Laboratories India Pvt Ltd., and a Partner by McKinsey & Co., Inc. He received his graduate degree from Université Libre de Bruxelles and a doctorate degree from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CODEXIS, INC. 0,08% | 17/06/2026 | 84 811 ( 0,08% ) | 144 179 $ | 31/08/2026 |
Dernières actualités sur Raymond de Vre
Postes actifs de Raymond de Vre
| Sociétés | Poste | Début |
|---|---|---|
| CODEXIS, INC. | Directeur/Membre du Conseil | 07/11/2024 |
| EQL PHARMA AB | Directeur/Membre du Conseil | 01/01/2025 |
Aurigene Oncology Ltd.
 Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Directeur/Membre du Conseil | - |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Président | - |
Anciens postes connus de Raymond de Vre
| Sociétés | Poste | Fin |
|---|---|---|
| POLYPEPTIDE GROUP AG | Directeur Général | 30/01/2023 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/01/2011 |
Formation de Raymond de Vre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
 EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Aurigene Oncology Ltd.
Aurigene Oncology Ltd. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Health Technology |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
PolyPeptide Group AG
 PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
